Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
2.37M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$26.4M
-
Value change
-
+$14.3M
-
Number of buys
-
9
-
Price
-
$11.17
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2014
11 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2014.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.37M shares
of 237M outstanding shares and own 1% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (877K shares), FMR LLC (423K shares), Broadfin Capital, LLC (389K shares), FRANKLIN RESOURCES INC (360K shares), Sio Capital Management, LLC (246K shares), Telemetry Investments, L.L.C. (67.1K shares), US BANCORP \DE\ (2K shares), SPRINGBOK CAPITAL MANAGEMENT, LLC (1.6K shares), MORGAN STANLEY (650 shares), and REGENTATLANTIC CAPITAL LLC (500 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.